Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
45,979,936
-
Share change
-
-472,026
-
Total reported value
-
$1,134,457,536
-
Put/Call ratio
-
141%
-
Price per share
-
$24.73
-
Number of holders
-
216
-
Value change
-
-$8,992,041
-
Number of buys
-
109
-
Number of sells
-
108
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2016
As of 30 Sep 2016,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) was held by
216 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,979,936 shares.
The largest 10 holders included
BlackRock Fund Advisors, VANGUARD GROUP INC, Invesco Ltd., ACADIAN ASSET MANAGEMENT LLC, Bank of New York Mellon Corp, GLENMEDE TRUST CO NA, Ranger Investment Management, L.P., Fiera Capital Corp, STATE STREET CORP, and BlackRock Institutional Trust Company, N.A..
This page lists
216
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.